Sue Macleman
Managing Director and Chief Executive Officer
Board of Director
MTP connect
Australia
Biography
Sue MacLeman has more than 25 years’ experience as a pharmaceutical, biotechnology and medical technology executive with roles in corporate, medical, commercial and business development at Schering-Plough Corporation (now Merck), Amgen, Bristol-Myers Squibb and Mesoblast Ltd. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the sector and is currently a non-executive director at RHS Ltd., veski and Oventus Medical Ltd. Sue has been recognised for her leadership with BioMelbourne Network’s 2017 Women in Leadership Award.
Research Interest
Pharmaceutical science, Biotechnology
